Markets.com Logo

012450

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --$
  • Previous Close
    --$
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --$
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

012450.KQ represents Celltrion Pharm Inc., a South Korean biopharmaceutical company listed on the Korea Exchange (KRX). Celltrion Pharm focuses on the development, manufacturing, and commercialization of biosimilars and novel drugs, particularly in the areas of autoimmune diseases, oncology, and infectious diseases. Its product portfolio includes biosimilars of infliximab and rituximab, and it also develops and markets a range of other pharmaceutical products.

Factors

Market Sentiment: Overall investor confidence and risk appetite influence demand, affecting stock prices.

Company Performance: Financial results, such as revenue, profit, and growth, drive investor perceptions.

Industry Trends: Sector-specific developments, regulations, and competition impact the company's prospects.

Economic Conditions: Macroeconomic factors like interest rates, inflation, and GDP growth affect profitability and investment.

Company News: Announcements regarding new products, partnerships, or management changes trigger price fluctuations.

People Also Watch

Latest news

Stellar (XLM) Price Analysis: Where could XLM go in the upcoming days?

Frances Wang|--

Crypto News Today: Bitcoin Price Down 1.85% as US PPI Rises

Frances Wang|--

Dogecoin Price Prediction: Could Dogecoin Price Surge to $0.95?

Ghko B|--

Latest Education Articles

Nvidia stock price prediction: Will NVDA Stock Hit $200 in 2025?

Ghko B|--

AI Stock Analysis: Who Are Nvidia’s Competitors?

Frances Wang|--

EV Stocks to Watch for June 2025: XPEV, SITM, RIVN, LI, BE

Frances Wang|--